Earnings Preview — 1605 total
CVS Health reports Q1 2026 results on May 6 as a stock that has quietly re-rated higher — and with the short sellers who drove much of the bearish narrative now stepping back. Short interest has fallen sharply over the…
Brown & Brown reports Q1 results on May 6 after shedding 12.5% in a single week — one of the sharpest drops in its peer group — leaving the stock at $57.63 and analysts scrambling to reset price targets before the…
BorgWarner heads into its May 6 Q1 earnings with options positioning at its most bullish in months — an unusually clean signal for a stock whose story has been anything but straightforward. The options market is the…
Banco Santander-Chile heads into its May 6 Q1 2026 earnings report with options traders the most defensively positioned they have been in the past year. The shift in sentiment is the clearest signal in the data. The…
BCH reports Q1 2026 results on May 6, entering the print with options and short data both pointing the same direction: investors are positioned for upside rather than bracing for a miss. Options sentiment is the…
BBD reports first-quarter results on May 6 with short sellers meaningfully less aggressive than they were just weeks ago. The short-side story is the most striking feature of the setup. Estimated short interest has…
Atmos Energy heads into its May 6 fiscal Q2 report with the analyst community largely neutral and short sellers quietly retreating. The strongest setup signal is in analyst positioning — and it tells a measured story.…
Cencora reports second-quarter results on May 6 against a backdrop of retreating analyst targets, mild short-side pressure, and a valuation that has quietly compressed heading into the release. The most telling setup…
Ameren reports Q1 results on May 6 with options positioning and analyst activity both tilting constructively — an unusual alignment for a utility heading into earnings. The options market is the clearest signal that…
Albemarle heads into its May 6 earnings release with short sellers at their most aggressive in months — and options traders adding to the cautious tone. Short interest has climbed sharply, from roughly 7% of the free…
Inno Holdings Inc. enters its May 4 earnings report in the grip of one of the most aggressive short-selling buildups visible in its recent history. Short interest has exploded to 74% of the free float — up from just…
ZGN heads into its May 4 first-quarter results as one of the most decisively bullish options setups in the luxury space right now. The options market is the clearest signal. Call demand has swamped puts so aggressively…
BigBear.ai heads into its May 5 Q1 report as one of the most heavily shorted small-cap AI names on the market, even as the stock climbs. Short sellers have dug in deep. At 28.2% of the free float, short interest is…
Rivian heads into Tuesday's Q1 print down 9% on the week and 8.4% in a single session — a sharp move that has left the stock lagging its EV peer group. The price drop stands out against the broader EV landscape. Tesla…
PLAYSTUDIOS reports Q1 results on May 5 with the stock trading at what the bear case describes as distressed valuations — and with shorts adding quietly while the price has slipped. The short-interest picture is modest…
Zeta Global Holdings reports Q1 2026 results on May 5 against a backdrop of rising short interest, freshly upgraded analyst coverage, and a stock that has recovered sharply off its lows — a rare combination that sets…
ULCC heads into its May 5 Q1 print having shed nearly half its short interest over six weeks — a remarkable capitulation from bears who once held more than 50% of the free float. Short sellers have been covering…
Eric Sprott has been buying HYMC every time it falls — and he's still buying. The mining billionaire has added 300,000 shares since April 9, spending roughly $11.5 million across three separate purchases. He now…
ARVN reports Q1 results on May 4 with analysts firmly constructive — but the stock trading nearly 20% below the consensus price target tells a story about a widening gap between conviction and reality. The analyst…
Axsome Therapeutics heads into its May 4 Q1 report as one of the more bullishly positioned CNS names in the market, with the stock up 22% over the past month and analyst targets rising in lockstep. The analyst…
